{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:39:51Z","timestamp":1792251591490,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.cmi.2015.12.025","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T08:01:43Z","timestamp":1453449703000},"page":"461.e1-461.e5","source":"Crossref","is-referenced-by-count":9,"title":["Maraviroc contributes to the restoration of the homeostasis of regulatory T-cell subsets in antiretroviral-naive HIV-infected subjects"],"prefix":"10.1016","volume":"22","author":[{"given":"M.M.","family":"Pozo-Balado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Rosado-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"M\u00e9ndez-Lagares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Rodr\u00edguez-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ruiz-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Benhnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.M.","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2015.12.025_bib1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cmi.2015.12.025_bib2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood-2012-07-409755","article-title":"The split personality of regulatory T cells in HIV infection","volume":"121","author":"Chevalier","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2015.12.025_bib3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI41072","article-title":"Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation","volume":"120","author":"Matsuoka","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cmi.2015.12.025_bib4","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.4049\/jimmunol.1001860","article-title":"Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes","volume":"185","author":"Marwaha","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2015.12.025_bib5","doi-asserted-by":"publisher","first-page":"e34662","DOI":"10.1371\/journal.pone.0034662","article-title":"Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus","volume":"7","author":"Pan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.025_bib6","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2015.12.025_bib7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/infdis\/jis011","article-title":"Dissection of a circulating and intrahepatic CD4+Foxp3+ T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states","volume":"205","author":"Zhang","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.025_bib8","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/QAD.0b013e32835e2b99","article-title":"Excessive conversion and impaired thymic output contribute to disturbed regulatory T-cell homeostasis in AIDS patients with low CD4 cell counts","volume":"27","author":"Zhou","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2015.12.025_bib9","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/infdis\/jis235","article-title":"Early and long-lasting alteration of effector CD45RA(-) Foxp3(high) regulatory T-cell homeostasis during HIV infection","volume":"205","author":"Simonetta","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.025_bib10","doi-asserted-by":"publisher","first-page":"e52580","DOI":"10.1371\/journal.pone.0052580","article-title":"Analysis of suppressor and non-suppressor FOXP3+ T cells in HIV-1-infected patients","volume":"7","author":"Arruvito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.025_bib11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.4049\/jimmunol.180.2.764","article-title":"Na\u00efve precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection","volume":"180","author":"Antons","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2015.12.025_bib12","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/infdis\/jiu180","article-title":"Maraviroc reduces Regulatory T cells in ART-na\u00efve HIV-infected subjects","volume":"210","author":"Pozo-Balado","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.025_bib13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/QAI.0b013e3181c5c83b","article-title":"CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2","volume":"54","author":"Asmuth","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cmi.2015.12.025_bib14","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1086\/598965","article-title":"A\u00a0double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1; A4001029 Study Group","volume":"199","author":"Saag","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.025_bib15","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.2119\/molmed.2012.00206","article-title":"CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection","volume":"18","author":"Westrop","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.cmi.2015.12.025_bib16","doi-asserted-by":"publisher","first-page":"e13188","DOI":"10.1371\/journal.pone.0013188","article-title":"Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients","volume":"5","author":"Funderburg","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.025_bib17","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1128\/AAC.01406-12","article-title":"Effect of maraviroc on HIV disease progression-related biomarkers","volume":"56","author":"Romero-S\u00e1nchez","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2015.12.025_bib18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1365-2249.2011.04409.x","article-title":"In\u00a0vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells","volume":"166","author":"Rossi","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cmi.2015.12.025_bib19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/infdis\/jis376","article-title":"A\u00a0pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4\u207a T-cell recovery despite sustained virologic suppression: ACTG A5256","volume":"206","author":"Wilkin","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.025_bib20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2015.06.018","article-title":"Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naive HIV-infected patients","volume":"121","author":"Genebat","year":"2015","journal-title":"Antivir Res"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T01:54:43Z","timestamp":1537062883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X16000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1198743X16000185"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.12.025","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}